We observed that GM‐CSF blockade significantly enhanced tumor growth in untreated mice (Fig. S5C) and impaired the antitumor activity upon triple treatment with 11% vs 90% of tumor volume inhibition in presence of GM‐CSF neutralizing antibody or isotype‐matched immunoglobulins, respectively (Fig. 6B). This evidence concerns the gene CSF2 and neoplasm.